The French over 55 years old will be able, "
from this Saturday
", to be administered the vaccine of Johnson & Johnson against the Covid-19, announced this Thursday the Minister of Health Olivier Véran.
To discover
Covid-19: instructions for use of self-tests
Read also: Europe's green light for Johnson & Johnson vaccine
Perfect timing to restore confidence in the French, the United States has just authorized the resumption of vaccination with Johnson & Johnson.
US health authorities gave the green light on Friday to resume vaccination with Johnson & Johnson's serum in the United States, suspended on April 13 after rare cases of thrombosis.
In Europe, the European Medicines Agency (EMA) has estimated that "
the benefits of the vaccine outweigh the risks
" despite a "
very rare
"
risk
of blood clots.
8 million doses by the end of June
France received a first shipment of 200,000 doses of the vaccine from Johnson & Johnson at the end of last week. "
The first 200,000 vaccines are delivered to pharmacies, doctors and liberal nurses who will be able to start offering it to their patients from this Saturday,
" said the Minister of Health during a press conference. The advantage of this vaccine is that it requires only one injection while the Pfizer / BioNTech, Moderna and AstraZeneca vaccines require two. Its conservation between 2 and 8 ° C facilitates its distribution and its storage.
France is expected to receive around eight million doses of this vaccine by the end of June, the health ministry said, with around 500,000 doses by the end of April.
By way of comparison, 47 million doses of the other three authorized vaccines will be delivered to France by June, two-thirds of which are supplied by Pfizer-BioNTech.
Read also: Covid-19: the United States authorizes the resumption of vaccination with Johnson & Johnson
In France, a quarter of the adult population has received at least one injection of a vaccine against the coronavirus.
Of these 13 million people, 5.3 million received two injections, or 8% of the total population and 10.3% of the adult population.
